Genius of the Rules-Style System

Chapter 666: Chapter 374: Wishing you success, keep going!_2

Even if the award went to Zhao Yi, the others who participated in the project could also bask in the glory!

Furthermore, they also released papers concerning related auxiliary results; thus, they can also sign the papers from major result researches.

For researchers in any field, influential results, worldwide recognized results, as well as papers are extremely important. Research outcomes and papers are their working outcomes. The more attention they receive, the more it represents the successful scientific research.

Everyone turned to look at Yan Xuelin with confusion.

Yan Xuelin chuckled, "The reason I went to Wucheng this time was for the drug development project. Because the results are ours, they invited us to synchronously develop drugs."

"Does that mean we’re getting another generous sponsorship?" Dai Tianqing was the first to catch on. freewёbnoνel.com

Ai Lixin hesitated and asked, "But we don’t specialize in drug development. We might not be able to solve problems encountered by their pharmaceutical company."

Yan Xuelin waved his hand and explained, "No problem. For confidentiality reasons, they can’t share information with any other parties, so their only option is to let us join the development process."

"Synchronous..."

Dai Tianqing hesitated and asked, "So that means we don’t share information and each do our own independent research?" fɾeeweɓnѳveɭ.com

Yan Xuelin nodded affirmatively, "Exactly! We develop simultaneously, with all expenses covered by them. If we achieve results, we’ll also get a share of the patent fees. That’s what I went to discuss this time, and they have agreed to give us an initial sponsorship of 10 million. If we ultimately succeed, we will own 30% of the drug patent."

"Their sponsorship means a 70-30 split...that’s not bad..." Dai Tianqing mused.

Ai Lixin retorted, "But we might not be able to deliver any results. The Pharma company’s research team must be facing major issues."

Yan Xuelin laughed, "Old Ai, don’t lose confidence. We haven’t even started yet. Even if we don’t yield any results, we won’t suffer any loss."

"That’s true." Everyone began to nod in agreement.

The matter was clear now.

When the pharmaceutical company was developing drugs and had problems that could not be solved in a short time, they simply turned to a research institute for help. Compared to the discovery of the 2CV-Bing Hydrogen Molecule, additional research funding was nothing big.

They cannot seek help from other organizations because the secrecy applies not only to the research institute but also to the people within the Pharmaceutical Company who have access to their information. Therefore, they either have to conduct in-house research or find a research institute to assist them in their research.

Yan Xuelin’s trip to Wucheng was to discuss this matter, and the final agreement was that the pharmaceutical company sponsors research while developing the drug simultaneously. If results are produced, they would be calculated based on patents, with them getting 70% of the patent ownership ratio.

Every research institution hopes to attract outside enterprise sponsorship for research funding. The Biomedical Research Institute is a national research institution, and most of its R&D funds are provided by the state. As they mostly engage in medical mechanism research, external enterprise sponsorship for research funding is scant.

The Biomedical Research Institute is not small in scale, but grants of 10 million from the beginning is indeed a massive project. More importantly, the institute will not incur any losses, all funds are taken care of by the pharmaceutical company, and whether or not results are yielded, the researchers involved will gain some drug development experience.

If results are successfully obtained, that would be even better. Thirty percent of patent ownership is indeed significant, especially for the 2CV-Bing Hydrogen Molecule patent.

The institute understands the effect of the 2CV-Bing Hydrogen Molecule very well. The drug developed around the 2CV-Bing Hydrogen Molecule will undoubtedly be effective against AIDS, and it may sell well domestically and internationally, leading to continuous substantial benefits from its 30% drug patent.

Furthermore, the development of AIDS drugs holds great significance. Currently, China does not have any domestically produced AIDS medicine available in the market; all prescribed drugs for treatment are imported. Since the research institute discovered the effect of the 2CV-Bing Hydrogen Molecule, having ’developed relevant drugs’ could double their honor.

Combining both economic benefits and honor would attract anyone.

...

Yan Xuelin dropped the big news about synchronous drug development, and their small internal meeting had just begun. He had visited the drug development base of a pharmaceutical company in Wucheng and understood the challenges faced in drug R&D.

In short, for now, there is no method to synthetically produce 2CV-Bing Hydrogen Molecules, and producing 2CV-Bing Hydrogen Molecules based on immunization process in a laboratory environment is too costly and inefficient.

The latter is self-explanatory.

When the 2CV-Bing Hydrogen Molecule was being studied previously, the lab-produced methods were based on simulating the immune environment, generating antibodies against a bacterial invasion, and consequently manufacturing the 2CV-Bing Hydrogen Molecule.

To extract the 2CV-Bing Hydrogen Molecule, one needs to continually interrupt experiments, add various chemical materials, and the process is extremely complicated. To extract a small tube of solution containing a trace amount of the 2CV-Bing Hydrogen Molecule, the lab cost could easily exceed ten thousand.

This small tube of solution would probably only be enough for two or three injections into the human body. With such treatment, the entire solution would be used up before any effect was even witnessed. But for the 2CV-Bing Hydrogen Molecule drug, a broad estimate would require continuous injections for at least half a month, or even one month, or two months, until all the AIDS virus in the blood is ’controlled,’ to achieve the best results.

In simple terms, a daily injection costs over three thousand RMB, and the average use of one month would cost around a hundred thousand RMB.